Cyclobarbital, cyclobarbitol or cyclobarbitone is a barbiturate derivative developed in the early 1970s in the Soviet Union.
Cyclobarbital, cyclobarbitol or cyclobarbitone is a barbiturate derivative developed in the early 1970s in the Soviet Union.
It was available in Russia until 2019, marketed and distributed as Reladorm, a fixed-dose combination pairing 100 mg cyclobarbital and 10 mg diazepam (a benzodiazepine anxiolytic, muscle relaxant, and anticonvulsant) indicated for treating insomnia before it was discontinued in 2019.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).